Home › Cardiovascular Disease › North Dakota › Fargo
Cardiovascular Disease clinical trials in Fargo, ND
4 studies for Cardiovascular Disease are looking for participants at sites in and around Fargo (within about 30 miles). Open a study to see who can join and how to contact the study team.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Lillestol Research, LLC, Fargo
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Fargo
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Fargo
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Lillestol Research LLC, Fargo
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- St. Louis, MO20 studies
- Pittsburgh, PA20 studies
- Nashville, TN19 studies
Other studies in Fargo
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer13 studies
- Cancer (all types)11 studies
- Melanoma9 studies
- Obesity9 studies
- Prostate Cancer8 studies
- Overweight8 studies
- Breast Cancer7 studies
- Colorectal Cancer7 studies
- Pancreatic Cancer6 studies
- Type 2 Diabetes6 studies
- Colon Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.